Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |